Recent clinical trials in atrial fibrillation in hypertensive patients
Current Hypertension Reports, 05/14/2012
Manolis AJ et al. – The older CHADS2 score and its more refined modern counterparts are well validated to determine stroke risk and guide antithrombotic therapy, but haemorrhagic risk has to be respected as well, and scores such as HAS–BLED should be widely used. Novel classes of anticoagulants that overcome many of the drawbacks of warfarin have been introduced with promising results and pose new questions that need to be answered in the near future.